NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 1,767.00
-738.00 (-29.46%)
Jun 10, 2026, 3:30 PM KST
NeoImmuneTech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -31,038 | -31,796 | -40,883 | -53,405 | -60,406 | -52,482 |
Depreciation & Amortization | 2,498 | 2,498 | 3,673 | 3,210 | 2,802 | 1,873 |
Loss (Gain) From Sale of Assets | -213.95 | -213.95 | 321.85 | 1.89 | 12.78 | 108.48 |
Asset Writedown & Restructuring Costs | 40.1 | 40.1 | 488.92 | - | - | - |
Stock-Based Compensation | -426.71 | -426.71 | 1,412 | 5,893 | 5,631 | 9,204 |
Provision & Write-off of Bad Debts | 118.84 | 118.84 | 936.2 | 225.98 | - | - |
Other Operating Activities | 5,472 | 5,923 | -2,018 | -2,138 | 2,909 | -271.91 |
Change in Accounts Receivable | -12.38 | -12.38 | -18.9 | - | - | - |
Change in Other Net Operating Assets | -1,183 | -1,183 | -2,975 | -3,548 | 6,646 | 7,682 |
Operating Cash Flow | -24,746 | -25,053 | -39,062 | -49,761 | -42,405 | -33,887 |
Capital Expenditures | 108.56 | -79.64 | -1,549 | -791.39 | -2,477 | -2,710 |
Sale of Property, Plant & Equipment | 275.42 | 230.49 | 1.26 | - | 6.98 | - |
Sale (Purchase) of Intangibles | -7,111 | -7,111 | - | - | - | - |
Investment in Securities | -9,445 | -9,445 | -12,403 | - | - | - |
Other Investing Activities | 1,257 | 1,278 | 2,381 | 2,715 | 836.55 | -1,119 |
Investing Cash Flow | -14,959 | -15,002 | -11,571 | 2,087 | -3,150 | -3,828 |
Long-Term Debt Issued | - | - | 12,403 | - | - | - |
Long-Term Debt Repaid | - | -792.78 | -1,186 | -1,178 | -1,036 | -713.73 |
Net Debt Issued (Repaid) | -727.95 | -792.78 | 11,217 | -1,178 | -1,036 | -713.73 |
Issuance of Common Stock | 48,688 | 48,688 | - | 41.26 | 402.56 | 115,763 |
Other Financing Activities | -1,036 | -1,036 | -0 | - | - | 0 |
Financing Cash Flow | 46,924 | 46,860 | 11,217 | -1,136 | -633.32 | 115,049 |
Foreign Exchange Rate Adjustments | -1,948 | -1,373 | -1,592 | -97.54 | -3,075 | -682.37 |
Miscellaneous Cash Flow Adjustments | -0 | - | -0 | -0 | -0 | - |
Net Cash Flow | 5,271 | 5,431 | -41,008 | -48,908 | -49,263 | 76,652 |
Free Cash Flow | -24,638 | -25,133 | -40,612 | -50,552 | -44,881 | -36,596 |
Free Cash Flow Margin | -4048.49% | -26504.37% | -23835.33% | - | - | - |
Free Cash Flow Per Share | -184.79 | -213.57 | -411.85 | -511.40 | -454.42 | -384.18 |
Cash Interest Paid | 236.78 | 213.82 | 221.25 | 220.99 | 253.77 | 226.7 |
Cash Income Tax Paid | - | -20.6 | 104.86 | 133.62 | 58.2 | 32.91 |
Levered Free Cash Flow | -19,368 | -20,882 | -24,302 | -38,500 | -28,855 | -25,579 |
Unlevered Free Cash Flow | -17,853 | -19,366 | -23,849 | -38,360 | -28,692 | -25,442 |
Change in Working Capital | -1,196 | -1,196 | -2,994 | -3,548 | 6,646 | 7,682 |